Fibroblastic reticular cells direct the initiation of T cell responses via CD44

Read full text
Authors: Xavier Y. X. Sng, Valentina Voigt, Iona S. Schuster, Peter Fleming, Felix A. Deuss, Mohammed H. Abuwarwar, Serani L. H. van Dommelen, Georgia E.G. Neate, Riley M. Arnold, Harry L. Horsnell, Sheridan Daly, Bagher Golzarroshan
+11 more Antiopi Varelias, Stewart D. Lyman, Anthony A. Scalzo, Geoffrey R. Hill, Scott N. Mueller, Matthew E. Wikström, Richard Berry, Jamie Rossjohn, Anne L. Fletcher, Christopher E. Andoniou, Mariapia A. Degli‐Esposti
Cited by: 2
References: 60

Abstract

Abstract The movement of dendritic cells and T cells within secondary lymphoid organs is critical for the development of adaptive immune responses 1,2 . Central to this process is the fibroblastic reticular cell (FRC) network, which forms a highly organized conduit system that facilitates the movement of and interactions between dendritic cells and T cells 3–6 . Previous studies have partly characterized how FRCs support these interactions 7,8 . However, the molecular mechanisms that operate under physiological conditions remain unknown. Here we show that the viral protein m11, encoded by the herpesvirus murine cytomegalovirus (CMV), inhibits antiviral immunity by targeting the FRC network and interfering with a critical function of cellular CD44. We found that m11 binds to CD44 and established that m11 perturbs the molecular interactions of CD44 with its natural ligand, hyaluronic acid. The interaction of m11 with CD44 impairs the trafficking of dendritic cells within the spleen, thereby impeding efficient priming of naive T cells and the initiation of antiviral CD8 T cell responses. The targeting of CD44 by CMV reveals CD44 as a molecule that is essential to the functioning of the FRC network and uncovers a previously unrecognized stroma-based mechanism that is critical for the generation of effective T cell responses.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Peptidase Inhibition and Analysis interferon and immune responses

Publication details

Journal / source
Nature
Publisher
Springer Science and Business Media LLC
Volume
651
Issue
8106
Pages
752–762
Publication date
21 January 2026
Language
EN